Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
PaperCitations, authors & open-access status
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 959 citations, 2019 year and bronze oa status.
959
Citations
2019
Year
bronze
OA Status